SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-013814
Filing Date
2021-02-24
Accepted
2021-02-24 16:39:07
Documents
1
Period of Report
2021-02-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5804
  Complete submission text file 0001209191-21-013814.txt   7423
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 640 LEE ROAD CHESTERBROOK PA 19087
Business Address
Saik Andrew (Reporting) CIK: 0001616284 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 21673954